135 related articles for article (PubMed ID: 3080233)
1. Direct and indirect effects of human recombinant gamma-interferon on tumor cells in a clonogenic assay.
Saito T; Berens ME; Welander CE
Cancer Res; 1986 Mar; 46(3):1142-7. PubMed ID: 3080233
[TBL] [Abstract][Full Text] [Related]
2. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the indirect antitumor effect of gamma-interferon using ascites-associated macrophages in a human tumor clonogenic assay.
Saito T; Berens ME; Welander EC
Cancer Res; 1987 Feb; 47(3):673-9. PubMed ID: 3100022
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro activation of alveolar macrophages by recombinant interferon-gamma.
Black CM; Catterall JR; Remington JS
J Immunol; 1987 Jan; 138(2):491-5. PubMed ID: 3098846
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Ia antigen expression in macrophages derived from bone marrow cells cultured in granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor.
Falk LA; Wahl LM; Vogel SN
J Immunol; 1988 Apr; 140(8):2652-60. PubMed ID: 3128601
[TBL] [Abstract][Full Text] [Related]
6. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.
Fidler IJ; Fogler WE; Kleinerman ES; Saiki I
J Immunol; 1985 Dec; 135(6):4289-96. PubMed ID: 3934281
[TBL] [Abstract][Full Text] [Related]
7. [Direct and indirect antitumor effect of murine recombinant interferons].
Sakurai M; Iigo M; Sasaki Y; Hoshi A; Saijo N
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):889-95. PubMed ID: 3105463
[TBL] [Abstract][Full Text] [Related]
8. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.
Hogan MM; Vogel SN
J Immunol; 1988 Dec; 141(12):4196-202. PubMed ID: 3143760
[TBL] [Abstract][Full Text] [Related]
9. Influence of fetal calf serum on growth-inhibitory activity of human recombinant gamma-interferon (GI-3) in vitro.
Hanada M; Shimoyama M
Jpn J Cancer Res; 1986 Nov; 77(11):1153-60. PubMed ID: 3098725
[TBL] [Abstract][Full Text] [Related]
10. IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy.
Han X; Wilbanks GD; Devaja O; Ruperelia V; Raju KS
Gynecol Oncol; 1999 Nov; 75(2):198-210. PubMed ID: 10525372
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of macrophage tumoricidal activity by glucocorticoids.
Hogan MM; Vogel SN
J Immunol; 1988 Jan; 140(2):513-9. PubMed ID: 3121748
[TBL] [Abstract][Full Text] [Related]
12. Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon.
Hori K; Ehrke MJ; Mace K; Mihich E
Cancer Res; 1987 Nov; 47(22):5868-74. PubMed ID: 3117358
[TBL] [Abstract][Full Text] [Related]
13. Antibody delivery and effector cell activation in a phase II trial of recombinant gamma-interferon and the murine monoclonal antibody CO17-1A in advanced colorectal carcinoma.
Weiner LM; Moldofsky PJ; Gatenby RA; O'Dwyer J; O'Brien J; Litwin S; Comis RL
Cancer Res; 1988 May; 48(9):2568-73. PubMed ID: 3128400
[TBL] [Abstract][Full Text] [Related]
14. Synergistic antitumor effects of tumor necrosis factor and gamma-interferon on human colon carcinoma cell lines.
Schiller JH; Bittner G; Storer B; Willson JK
Cancer Res; 1987 Jun; 47(11):2809-13. PubMed ID: 3105867
[TBL] [Abstract][Full Text] [Related]
15. Lipid A-associated proteins provide an alternate "second signal" in the activation of recombinant interferon-gamma-primed, C3H/HeJ macrophages to a fully tumoricidal state.
Hogan MM; Vogel SN
J Immunol; 1987 Dec; 139(11):3697-702. PubMed ID: 3119714
[TBL] [Abstract][Full Text] [Related]
16. Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma.
Ruggiero V; Tavernier J; Fiers W; Baglioni C
J Immunol; 1986 Apr; 136(7):2445-50. PubMed ID: 3005411
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo activation of human mononuclear phagocytes by interferon-gamma. Studies with normal and AIDS monocytes.
Murray HW; Scavuzzo D; Jacobs JL; Kaplan MH; Libby DM; Schindler J; Roberts RB
J Immunol; 1987 Apr; 138(8):2457-62. PubMed ID: 3104467
[TBL] [Abstract][Full Text] [Related]
18. Effects of recombinant interferons on the clonogenic growth of leukemic cells and normal hemopoietic progenitors.
Hosoi T; Ozawa K; Urabe A; Takaku F
Int J Cell Cloning; 1985 Sep; 3(5):304-12. PubMed ID: 3930631
[TBL] [Abstract][Full Text] [Related]
19. The effect of recombinant interferon-gamma on human monocyte-derived macrophages.
Jungi TW; Lerch PG; Brcic M
Eur J Immunol; 1987 May; 17(5):735-8. PubMed ID: 3108018
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma synergizes with tumor necrosis factor and with interleukin 1 and requires the presence of both monokines to induce antitumor cytotoxic activity in macrophages.
Chen L; Suzuki Y; Wheelock EF
J Immunol; 1987 Dec; 139(12):4096-101. PubMed ID: 3121728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
